Abstract
Hip osteoarthritis (OA) is usually managed with systemic treatments such as nonsteroidal anti-inflammatory drugs (NSAIDs) and/or symptomatic slow-acting drugs. Unfortunately, many patients either cannot tolerate NSAIDs or suffer serious, even fatal, NSAID-induced side effects, predominantly gastrointestinal ulceration and bleeding. Viscosupplementation, which aims to restore physiological and rheological features of the synovial fluid, is a well-accepted therapeutic option in knee OA patients, but limited data exist in the literature about its potential benefit for the treatment of hip OA. The purpose of this study is to observe the effects of hylan G-F 20 administered through ultrasound (US)-guided intra-articular (IA) injections in patients with symptomatic hip OA. We treated 30 patients with symptomatic hip OA. Under US guidance, 7 patients received one injection, 21 patients had two injections, and 2 patients received three injections, each with 2 ml of hylan G-F 20. Lequesne index, VAS scale of hip pain, and NSAID consumption were evaluated at baseline as well as 2 and 6 months after the beginning of the treatment. No systemic adverse events were observed. Lequesne index, VAS pain score, and NSAID consumption showed a reduction that was statistically significant to the baseline. The present observation suggests the potentiality for the safety and efficacy of hylan G-F 20 injected under US guidance in patients with symptomatic hip OA. Further controlled studies are needed.
References
Balazs EA, Denlinger JL (2003) Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 20(39):2–9
Altman RD, Hochberg MC, Moskowitz RW, Schnitzer TJ (2000) Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 43:1905–1915
Espallargues M, Pons JM (2003) Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review. Int J Technol Assess Health Care 19(1):41–56
Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N (2002) A prospective, randomized, pragmatic health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): clinical results. Osteoarthritis Cartilage 10:506–517
Adams ME, Atkinson MH, Lussier A, Schulz JI, Siminovitch KA, Wade JP et al (1995) The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F alone, hylan G-F 20 with nonsteroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 3:213–226
Tamir E, Robinson D, Koren R, Agar G (2001) Intra-articular hyaluronan for the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled study. Clin Exp Rheumatol 19:265–270
Kolarz G, Kotz R, Hochmayer I (2003) Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 32(5):310–319
Wobig M, Dickhut A, Maier R, Vetter G (1998) Viscosupplementation with hylan G-F 20: a 26 week controlled trial of efficacy and safety in the osteoarthritis knee. Clin Ther 20:410–423
Dickson DJ, Hosie G, English JR et al (2001) A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Res 4:41–52
Brocq O, Tran G, Breuil U, Grisot C, Flory P, Euller-Zuegler L (2002) Hip osteoarthritis: short term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 69(4):388–391
Migliore A, Martin Martin LS, Alimonti A et al (2003) Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 11:305–306
Migliore A, Martin Martin LS, Valente C, Alimonti A, Bernardini A, Monno D, Tormenta S (2002) Intra-articular treatment with Hylan G-F 20 (Synvisc) reduces NSAIDS consumption in patients with symptomatic osteoarthritis of the hip: preliminary clinical observations. Osteoporosis Int 13(3):S20
Conrozier T, Bertin P, Mathieu P, Charlot J, Bailleul F, Treves R, Vignon E, Chevalier X (2003) Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open label, multicentre, pilot study. Clin Exp Rheumatol 21 605–610
Leopold SS, Battista V, Oliverio JA (2001) Safety and efficacy of intraarticular hip injection using anatomic landmarks. Clin Orthop Relat Res Oct(391):192–197
Jackson DW, Evans NA, and Thomas BM (2002) Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 84A:1522–1527
Qvistgaard E, Kristoffersen H, Terslev L, Danneskiold-Samsoe B, Torp-pedersen S, Bliddal H (2001) Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthritis Cartilage 9:512–517
Migliore A, Tormenta S, Martin LS, Valente C, Massafra U, Granata M, Alimonti A (2004) Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol Dec 9 (Epub ahead of print)
Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502
Lequesne MG (1997) The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 24(4):779–781
Sturkenboom MC, Romano F, Simon G, Correa-Leite ML, Villa M, Nicolosi Á, Borgnolo G, White-Porro G, Mannino S (2002) The iatrogenic costs of NSAID therapy: a population study. Arthritis Rheum 47(2):132–140
Page J, Henry D (2000) Consumption of NSAIDs and development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 160:777–784
Larsen NE, Balazs EA (1991) Drug delivery system using hyaluronan and its derivatives. Adv Drug Deliv Rev 7:279–293
Weiss C, Band P (1995) Musculokeletal applications of hyaluronan and hylan. Potential uses in the foot and ankle. Clin Podiatr Med Surg 12:497–517
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Migliore, A., Tormenta, S., Martin Martin, L.S. et al. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin Rheumatol 25, 389–393 (2006). https://doi.org/10.1007/s10067-005-0052-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-0052-x